# The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

> **NCT00056368** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 256 (actual)

## Conditions studied

- Candidiasis

## Interventions

- **DRUG:** Anidulafungin
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT00056368
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2008-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00056368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00056368, "The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00056368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*